DJ-1 activates autophagy in the repression of cardiac hypertrophy

Ruicong Xue1, Jingzhou Jiang1, Bin Dong1

  • 1Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China; Key Laboratory on Assisted Circulation, Ministry of Health, Guangzhou, China.

Insights

DJ-1 protein deficiency worsens cardiac hypertrophy and autophagy impairment. Restoring DJ-1 levels may protect against heart failure by activating autophagy.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cell Biology

Background:

  • Cardiac hypertrophy is a risk factor for heart failure.
  • Autophagy regulates cardiac hypertrophy.
  • DJ-1 protein's role in autophagy and cardiac hypertrophy is unclear.

Purpose of the Study:

  • Investigate DJ-1's role in cardiac hypertrophy.
  • Determine if DJ-1 modulates autophagy during cardiac hypertrophy.
  • Explore DJ-1's potential as a therapeutic target for heart failure.

Main Methods:

  • Studied DJ-1 expression in pressure overload-induced cardiac hypertrophy models.
  • Utilized DJ-1 knockout mice and in vitro cell models.
  • Analyzed autophagy markers, mTORC1/mTORC2 phosphorylation, and cardiac hypertrophy phenotypes.

Main Results:

  • DJ-1 expression decreased in cardiac hypertrophy, correlating with impaired autophagy.
  • DJ-1 knockout mice showed exacerbated cardiac hypertrophy and pulmonary edema.
  • DJ-1 deficiency impaired autophagy activation and enhanced mTORC1/mTORC2 phosphorylation.
  • DJ-1 overexpression ameliorated phenylephrine-induced cardiac hypertrophy and promoted autophagy.

Conclusions:

  • DJ-1 represses cardiac hypertrophy through autophagy activation.
  • DJ-1 deficiency exacerbates cardiac hypertrophy by inhibiting autophagy.
  • DJ-1 is a potential therapeutic target for preventing or treating cardiac hypertrophy and heart failure.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
550
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
628
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
634